View in EDS

Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors.

Saved in:
Bibliographic Details
Title: Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors.
Authors: Drengler RL; University of Texas Health Science Center at San Antonio, USA., Kuhn JG, Schaaf LJ, Rodriguez GI, Villalona-Calero MA, Hammond LA, Stephenson JA Jr, Hodges S, Kraynak MA, Staton BA, Elfring GL, Locker PK, Miller LL, Von Hoff DD, Rothenberg ML
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1999 Feb; Vol. 17 (2), pp. 685-96.
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Print ISSN: 0732-183X (Print) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 10080615
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Drengler+RL%22">Drengler RL</searchLink>; University of Texas Health Science Center at San Antonio, USA.<br /><searchLink fieldCode="AU" term="%22Kuhn+JG%22">Kuhn JG</searchLink><br /><searchLink fieldCode="AU" term="%22Schaaf+LJ%22">Schaaf LJ</searchLink><br /><searchLink fieldCode="AU" term="%22Rodriguez+GI%22">Rodriguez GI</searchLink><br /><searchLink fieldCode="AU" term="%22Villalona-Calero+MA%22">Villalona-Calero MA</searchLink><br /><searchLink fieldCode="AU" term="%22Hammond+LA%22">Hammond LA</searchLink><br /><searchLink fieldCode="AU" term="%22Stephenson+JA+Jr%22">Stephenson JA Jr</searchLink><br /><searchLink fieldCode="AU" term="%22Hodges+S%22">Hodges S</searchLink><br /><searchLink fieldCode="AU" term="%22Kraynak+MA%22">Kraynak MA</searchLink><br /><searchLink fieldCode="AU" term="%22Staton+BA%22">Staton BA</searchLink><br /><searchLink fieldCode="AU" term="%22Elfring+GL%22">Elfring GL</searchLink><br /><searchLink fieldCode="AU" term="%22Locker+PK%22">Locker PK</searchLink><br /><searchLink fieldCode="AU" term="%22Miller+LL%22">Miller LL</searchLink><br /><searchLink fieldCode="AU" term="%22Von+Hoff+DD%22">Von Hoff DD</searchLink><br /><searchLink fieldCode="AU" term="%22Rothenberg+ML%22">Rothenberg ML</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 1999 Feb; Vol. 17 (2), pp. 685-96.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0732-183X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=10080615
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.1999.17.2.685
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 685
    Titles:
      – TitleFull: Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Drengler RL
      – PersonEntity:
          Name:
            NameFull: Kuhn JG
      – PersonEntity:
          Name:
            NameFull: Schaaf LJ
      – PersonEntity:
          Name:
            NameFull: Rodriguez GI
      – PersonEntity:
          Name:
            NameFull: Villalona-Calero MA
      – PersonEntity:
          Name:
            NameFull: Hammond LA
      – PersonEntity:
          Name:
            NameFull: Stephenson JA Jr
      – PersonEntity:
          Name:
            NameFull: Hodges S
      – PersonEntity:
          Name:
            NameFull: Kraynak MA
      – PersonEntity:
          Name:
            NameFull: Staton BA
      – PersonEntity:
          Name:
            NameFull: Elfring GL
      – PersonEntity:
          Name:
            NameFull: Locker PK
      – PersonEntity:
          Name:
            NameFull: Miller LL
      – PersonEntity:
          Name:
            NameFull: Von Hoff DD
      – PersonEntity:
          Name:
            NameFull: Rothenberg ML
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 1999 Feb
              Type: published
              Y: 1999
          Identifiers:
            – Type: issn-print
              Value: 0732-183X
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1